Hbk Sorce Advisory LLC Astrazeneca PLC Transaction History

Hbk Sorce Advisory LLC

$2.56 Billion
Q3 2024

A detailed history of Hbk Sorce Advisory LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Hbk Sorce Advisory LLC holds 8,125 shares of AZN stock, worth $543,075. This represents 0.02% of its overall portfolio holdings.

Number of Shares

8,125

Previous 8,828 7.96%

Holding current value

$543,075

Previous $688,000 7.99%

% of portfolio

0.02%

Previous 0.03%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$76.67 - $87.62 $53,899 - $61,596	-703 Reduced 7.96%	8,125 $633,000
Q2 2024 Aug 08, 2024	BUY	$66.81 - $80.83 $22,047 - $26,673	330 Added 3.88%	8,828 $688,000
Q1 2024 May 09, 2024	BUY	$61.03 - $69.57 $11,961 - $13,635	196 Added 2.36%	8,498 $575,000
Q4 2023 Jan 25, 2024	SELL	$61.89 - $69.28 $5,260 - $5,888	-85 Reduced 1.01%	8,302 $559,000
Q3 2023 Nov 06, 2023	BUY	$64.85 - $71.7 $3,047 - $3,369	47 Added 0.56%	8,387 $567,000
Q2 2023 Aug 04, 2023	SELL	$69.91 - $75.81 $586,754 - $636,273	-8,393 Reduced 50.16%	8,340 $596,000
Q1 2023 Aug 15, 2023	BUY	$63.15 - $71.6 $10,798 - $12,243	171 Added 2.05%	8,511 $590,000
Q1 2023 May 15, 2023	SELL	$63.15 - $71.6 $72,811 - $82,554	-1,153 Reduced 6.45%	16,733 $1.77 Million
Q4 2022 Feb 09, 2023	BUY	$54.21 - $70.44 $247,468 - $321,558	4,565 Added 34.27%	17,886 $1.21 Million
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $104,396 - $267,291	1,969 Added 17.34%	13,321 $672,000
Q2 2022 Aug 15, 2022	SELL	$59.26 - $71.14 $181,750 - $218,186	-3,067 Reduced 21.27%	11,352 $750,000
Q1 2022 May 13, 2022	SELL	$55.72 - $67.12 $221,264 - $266,533	-3,971 Reduced 21.59%	14,419 $957,000
Q4 2021 Feb 15, 2022	BUY	$54.02 - $63.83 $18,528 - $21,893	343 Added 1.9%	18,390 $1.07 Million
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $119,509 - $130,759	2,151 Added 13.53%	18,047 $1.08 Million
Q2 2021 Aug 12, 2021	BUY	$48.42 - $60.18 $138,093 - $171,633	2,852 Added 21.86%	15,896 $952,000
Q1 2021 May 14, 2021	SELL	$47.16 - $54.44 $69,136 - $79,809	-1,466 Reduced 10.1%	13,044 $649,000
Q4 2020 Feb 12, 2021	SELL	$48.52 - $58.02 $123,628 - $147,834	-2,548 Reduced 14.94%	14,510 $725,000
Q3 2020 Nov 13, 2020	SELL	$53.07 - $61.1 $148,277 - $170,713	-2,794 Reduced 14.07%	17,058 $935,000
Q2 2020 Aug 14, 2020	BUY	$43.1 - $55.31 $576,893 - $740,324	13,385 Added 206.97%	19,852 $1.05 Million
Q1 2020 May 15, 2020	BUY	$37.79 - $51.33 $57,516 - $78,124	1,522 Added 30.78%	6,467 $289,000
Q4 2019 Feb 13, 2020	BUY	$42.46 - $50.46 $209,964 - $249,524	4,945 New	4,945 $247,000
Q2 2018 Aug 10, 2018	SELL	$34.55 - $37.05 $209,580 - $224,745	-6,066 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$32.97 - $36.63 $7,912 - $8,791	-240 Reduced 3.81%	6,066 $212,000
Q4 2017 Feb 15, 2018	BUY	$32.09 - $34.78 $202,359 - $219,322	6,306	6,306 $219,000

Others Institutions Holding AZN

# of Institutions

1,360

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $207B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hbk Sorce Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hbk Sorce Advisory LLC with notifications on news.

Account

Hbk Sorce Advisory LLC Astrazeneca PLC Transaction History